Weekly Market Recap: Accelevation, Oura's Delay, and Anthropic's Leaked S-1 — Week of September 28

A quieter-than-hoped week for US new issues: the one sizable operating-company deal, AI data-center supplier Accelevation, priced below its marketed range, while a headline consumer-tech listing was reportedly postponed and leaked details from Anthropic's confidential S-1 reignited the debate over mega-cap AI pre-IPO valuations. Below, we separate what is confirmed from what is estimate or rumor. For the full list of deals, see our IPO Calendar.

This Week's Debuts

• Accelevation Holdings (ACCV), Nasdaq: priced 30 million shares at $18.00, below the $20–$24 marketed range, raising about $540 million (roughly 71% of shares were sold by existing holders). Shares began trading Sep 30 and were reported down about 2.5% at the open ($17.55). The company makes power-distribution and infrastructure products for AI data centers; Olympus Partners retains majority voting control.
• Southport Acquisition Corp. II (PORT.U): $200 million SPAC priced at $10.00 on Oct 1. No operating business at IPO.
• Chilwa Minerals (CHWM): small uplisting priced at $5.60 (about $3.5 million).
• Siyata PTT (PTT): direct listing with a $7.00 reference price (about $42.8 million est.) scheduled for Oct 1; we did not confirm first-day trading.

Fact vs. estimate: price, share count and deal size for Accelevation are confirmed by IPOScoop and Renaissance Capital reporting; the first-day move is an early/opening figure from a single outlet and may differ from the closing price. First-day closes for the other names were not available at the time of writing.

Pre-IPO Watch: Anthropic and Oura

Anthropic. Reuters and the Financial Times reported on Sep 28–29 details from the company's confidential S-1, as summarized by SiliconANGLE: revenue of about $4.6 billion in 2025 (versus $400 million in 2024), roughly $11.5 billion in Q2 2026 alone, a 2025 operating loss of about $8 billion, and a net loss of about $42 billion, driven largely by a roughly $34 billion accounting charge tied to investor funding. The same reporting says infrastructure commitments total about $518 billion, with around 80% tied to non-cancellable or take-or-pay contracts. The company has not made the S-1 public; the last priced private round was $965 billion (Series H, May 2026). Reports that it may seek a listing as early as November at a valuation of $2 trillion or more, raising up to $100 billion, are unconfirmed estimates. Opportunity: extraordinary revenue growth. Risks: large losses, heavy fixed infrastructure obligations, and a valuation that already assumes continued hypergrowth.

Oura. IPOScoop's pre-pricing note had Oura (OURA) targeting a $40–$44 range for about $2.1 billion at the midpoint, and states that the deal was later postponed on market conditions. We could not corroborate the postponement with a second independent source, so treat it as reported but unverified.

What's Ahead Next Week

• AfterNext Acquisition I Corp. (AFNXU): $100 million SPAC at $10.00, expected Wednesday, Oct 7.
• BW Industrial Holdings (BWGC) ($6–$7, about $17.1M) and Web3Labs Global (MDAT) ($4–$5, about $28.1M): micro-cap deals still listed as "week of" and subject to slipping.

The calendar is thin; the main swing factor is whether postponed or delayed larger deals return. Dates are estimates until pricing is announced. See the updated IPO Calendar.

Why It Matters for Pre-IPO and Tokenized Equity Investors

Renaissance Capital's Q3 review describes IPO activity as below expectations, citing AI spending concerns, bond yields at a 19-year high and resumed rate hikes. Accelevation pricing 25% below the midpoint of its range suggests public investors are paying less of a premium for AI-linked growth, even for a company that reported rapid revenue growth. That matters for private-market holdings and tokenized equity products that reference late-stage AI companies, because secondary prices tend to follow public comparables. Opportunities: more disciplined IPO pricing can mean better entry points and cleaner after-market trading. Risks: postponed deals, valuation resets, thin liquidity in micro-caps, and the fact that tokenized or synthetic exposure to a company like Anthropic is not the same as owning registered shares. This analysis is not a forecast of any specific price.

This material is for informational purposes only and does not constitute individual investment advice.

Sources

• IPOScoop — IPO Calendar
• IPOScoop — The IPO Buzz: Oura & Accelevation
• Renaissance Capital — Accelevation sets terms
• Renaissance Capital — 3Q 2026 US IPO Market Review
• BigGo Finance — Accelevation shares slip in Nasdaq debut
• Investing.com — Accelevation prices IPO at $18 per share
• SiliconANGLE — Leaked Anthropic IPO filing
• Empower — Anthropic IPO: where things stand